News

Transgene Shares Trading Pause Announced on Euronext Paris

Transgene Shares Trading Pause Announced on Euronext Paris

Transgene Announces Share Trading Suspension

Transgene (Euronext Paris: TNG) has requested a trading suspension for its shares on Euronext Paris starting on the morning of November 26, pending the announcement of its capital increase results. This decision is made to ensure that all investors have access to the necessary information before trading resumes.

Expected Resumption of Trading

It is anticipated that trading will resume on November 27, allowing investors to re-engage with the market under updated circumstances. The process aims to provide clarity and maintain transparency for stakeholders.

Communication Channels for Investors

For additional information and answers to inquiries, investors can reach out via the following contacts:

Transgene:
Caroline Tosch, Corporate and Scientific Communications Manager
Contact: +33 (0)3 68 33 27 38
Email: communication@transgene.fr

Investors & Analysts:
Lucie Larguier, Chief Financial Officer (CFO)
Email: investorrelations@transgene.fr
Contact: +33 (0)3 88 27 91 00/03

About Transgene

Transgene is a pioneering biotechnology company focused on developing immunotherapy products for cancer treatment. The company's innovative portfolio features several viral vector-based immunotherapies currently undergoing clinical evaluation. TG4050 stands out as the lead candidate, utilizing the advanced myvac® platform tailored to deliver personalized treatments, and has shown promising results for patients with head and neck cancer.

Innovation and Technology

Transgene continually explores cutting-edge technologies designed to improve patient outcomes. Through its myvac® immunotherapy, the company delivers individualized treatments that leverage artificial intelligence to identify and select specific tumor mutations, integrating them into viral vectors.

Research and Development Focus

The company also explores other promising candidates, including BT-001, a cutting-edge oncolytic virus emerging from the invir.IO® platform. This platform underlines Transgene's commitment to innovation and exploration in their field, setting the stage for the development of next-generation therapies.

Frequently Asked Questions

What prompted the suspension of trading?

The suspension was requested to provide clarity and transparency for investors regarding the upcoming announcements related to the capital increase.

When will trading resume?

Trading is expected to resume on November 27, allowing investors to react to updated information.

Who can I contact for more information?

Investors can reach out to Caroline Tosch or Lucie Larguier through their provided contact information for inquiries.

What is Transgene's primary focus?

Transgene is dedicated to developing personalized immunotherapy products for cancer treatment, leveraging viral vector technology.

How can I stay updated on Transgene's developments?

Follow Transgene on their social media platforms for the latest news and updates about their research and advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AI Innovation Incubator Shakes Up Shanghai's Lingang

Updated Category News Views 112

Incubator Conference Lights Up Lingang Hold onto your hats, folks! Shanghai's Lingang Center is buzzing with activity as the 'World Top-performing Incubator Conference 2026' kicks off. Taking place from October 26 to 28, this gathering isn't just another run-of-the-mill tech meet-up. Oh no, it's about redefining how we talk about innovation, incubation, and the future,...

Continue Reading
XCMG Lends Heavy Equipment to Nairobi Rescue Effort

Updated Category News Views 57

When Buildings Fall and Heavy Equipment Matters Buildings aren't supposed to just topple over. It's not some new trend I missed, but when it does happen, you've got a crisis – and that's exactly what unfolded in Nairobi on October 23 when an 18-story tower gave out, crashing down into chaos in the Eastleigh neighborhood. From Ground Zero to Immediate Response Imagine...

Continue Reading
Real-World Study Shows Viable Use of Tarlatamab

Updated Category News Views 0

Breaking New Ground in Cancer Care There's a shift happening in the realm of cancer treatment, and OneOncology's latest study on tarlatamab is right at the forefront. Bringing advanced therapies closer to home isn't just a pipe dream anymore. This real-world study, unveiled at the 2026 ESMO Congress, underscores that administering tarlatamab in outpatient settings might...

Continue Reading
Yuchai Eyes African Market Expansion with Strategic Visits

Updated Category News Views 49

Yuchai's Bold Move into Africa There's something gutsy about a company that doesn't just sit on its achievements but heads out into new territories. China Yuchai International (NYSE: CYD), a big player in powertrain solutions, recently embarked on a strategic tour across the African continent, a move that could well shape their future market playbook. East Africa:...

Continue Reading
Gilded Dragonfly Gallery: A Jewel in Brunswick's Crown

Updated Category News Views 22

There's something remarkable happening in Brunswick, Maryland. This small town's stirring to life with a splash of creativity, and it's just gotten a little brighter with the grand opening of the Gilded Dragonfly Gallery. This isn't just another art gallery popping up; it's a statement of transformation, from quiet exurbia to a thriving arts destination. Jayme Marshall:...

Continue Reading
Unlocking Airbnb Success: Expert Tips on Design Features

Updated Category News Views 0

Design's Role in Capturing Airbnb Guests Alright, folks, let's dissect what really gets those Airbnb bookings. Wendy Anguiano, no stranger to sprucing up coastal rentals, dishes the dirt on design elements that scream 'book me' on first click. She's hailed from Design & Dwell Homes, operating right from the heart of Santa Rosa Beach, Florida. It's a fierce market out...

Continue Reading
Canton Fair 2026: Tech and Tradition Transform Jewelry

Updated Category News Views 109

Tech-Savvy Elegance at Canton Fair Dive into the glitz and glamour of the jewelry zone at the 140th Canton Fair, where technology and craftsmanship are forging a new narrative for luxury accessories. This isn’t just your grandmother’s jewelry box we're talking about anymore. We’re witnessing the dawn of precious metal smart rings and dual-band smart watches that...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 12

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Medefy's New Award Honors Cost-Savvy Consultants

Updated Category News Views 11

Awarding Ingenuity in Healthcare Cost Containment Ditch the chatter, folks. Let’s talk about a little piece of news that just might be the ripple effect the healthcare sector needs right now. Medefy, that cost-containment whiz, has unleashed 'The Curve Bender Award.' Frankly, it's about time someone spotlighted the gritty work of benefits consultants grinding in the...

Continue Reading
IBSSC 2026: A New Chapter in Business Education

Updated Category News Views 50

Shifts in Business Education at the IBSSC 2026 Boy, oh boy, Shanghai was buzzing the other week. We’re diving into the heart of the 11th International Business School Shanghai Conference (IBSSC). There's a changing of the guard in how business education is viewed, and it was all happening from October 21 to 23 at the Xuhui campus of Shanghai Jiao Tong University. Global...

Continue Reading

Top 5 Most Recently Viewed Articles

LeoStella and BlackSky Propel Space Innovation through HALO

Updated Category News Views 130

LeoStella and BlackSky Join Forces for Space Development In a significant advancement in space technology, LeoStella has been chosen by the Space Development Agency (SDA) to participate in the Hybrid Acquisition for Proliferated Low-Earth Orbit (HALO) program. This project marks an exciting turn for nontraditional defense firms, allowing them to engage directly with SDA...

Continue Reading
Medical Care Technologies Implements Strategic Share Reduction

Updated Category News Views 94

Medical Care Technologies Initiates Share Reduction Plan Medical Care Technologies Inc. (MDCE) / Infinite Auctions has embarked on an important initiative to enhance its financial health and shareholder value by reducing the outstanding share count. This initial step involves slashing 200 million shares in what the company refers to as Phase One of this strategic plan....

Continue Reading
Innovent's Arcotatug Tavatecan: A Potential Game Changer

Updated Category News Views 14

Innovent's New Kid on the Block Alright, let's dive into the nitty-gritty of Innovent Biologics and their latest scientific marvel, arcotatug tavatecan. It's not every day you hear about a potential game-changer in the oncology world, but this CLDN18.2-targeted ADC seems to be creating quite the stir. For a company founded with the mission of making high-quality medicines...

Continue Reading
SolarBank Set to Announce Annual Results and Host Webinar Event

Updated Category News Views 87

SolarBank to Share Annual Financial Results SolarBank Corporation (CSE: SUNN, NASDAQ: SUUN) is preparing to unveil its annual financial results, an important occasion for both stakeholders and investors. Recently, the company announced it would release its results for the year ending June 30, 2024, following the close of trading on the Nasdaq market. An engaging webinar...

Continue Reading
Reviewing the Sprinklr Class Action Filing: What to Know for Investors

Updated Category News Views 235

Understanding the Class Action Lawsuit Involving Sprinklr, Inc. Investors today are continuously seeking secure avenues for their financial assets. However, events can unfold that may alter their initial expectations. The latest developments surrounding Sprinklr, Inc. (NYSE: CXM) have prompted an important class action announcement. This notice is crucial for shareholders...

Continue Reading